Will booster doses be required for serogroup B meningococcal vaccine?
The European licensure of 4CMenB, the first vaccine licensed to prevent non-epidemic meningococcal B (MenB) disease, marked an important milestone in the fight against meningococcal disease. However, the potential introduction of 4CMenB into the routine infant schedule is complicated by a number of...
Main Authors: | McQuaid, F, Snape, MD |
---|---|
פורמט: | Journal article |
שפה: | English |
יצא לאור: |
2014
|
פריטים דומים
-
Long-term seroprotection after an adolescent booster meningococcal serogroup C vaccination
מאת: De Whalley, P, et al.
יצא לאור: (2013) -
Long-term seroprotection after an adolescent booster meningococcal serogroup C vaccination.
מאת: de Whalley, P, et al.
יצא לאור: (2013) -
Persistence of bactericidal antibodies following early infant vaccination with a serogroup B meningococcal vaccine and immunogenicity of a preschool booster dose.
מאת: Snape, MD, et al.
יצא לאור: (2013) -
Persistence of bactericidal antibodies following early infant vaccination with a serogroup B meningococcal vaccine and immunogenicity of a preschool booster dose
מאת: Snape, M, et al.
יצא לאור: (2013) -
Adolescents need a booster of serogroup C meningococcal vaccine to protect them and maintain population control of the disease.
מאת: Pollard, A, et al.
יצא לאור: (2013)